BDX · News · 20260809N

Product Launch and Transition

BECTON DICKINSON & CO · 2026-08-09 · Importance 31 · Surprise 42

Becton Dickinson reported momentum in biologic drug delivery, including partnerships tied to GLP-1 medicines. In Brazil, the company is collaborating on a semaglutide pen using its Vystra Injection Pen platform. The collaboration supports positioning in injectable-device applications for diabetes and obesity treatments.

Key facts